Your browser doesn't support javascript.
loading
Response to: 'Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors' by Meyer et al.
Rosenzwajg, Michelle; Lorenzon, Roberta; Klatzmann, David.
Afiliação
  • Rosenzwajg M; AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (i2B), F-75013, Paris, France, AP-HP, Paris, France.
  • Lorenzon R; Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), Sorbonne Unversité, Paris, France.
  • Klatzmann D; AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (i2B), F-75013, Paris, France, AP-HP, Paris, France.
Ann Rheum Dis ; 80(12): e197, 2021 12.
Article em En | MEDLINE | ID: mdl-31964656

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article